|United States Of America||Issued Patent||9,708,646||06/18/2017||2010-028|
|United States Of America||Issued Patent||9,605,246||03/28/2017||2010-028|
|United States Of America||Issued Patent||9,115,348||08/25/2015||2010-028|
DNA restriction enzymes transformed molecular biology in the 1970s by making it possible to cleave specific DNA sequences at will. Sequencing of RNA molecules currently entails copying the RNA into a DNA strand that is then sequenced by conventional methods. This approach, also known as RNASeq, is robust and can yield many millions of sequence reads. However, the necessity of generating cDNA introduces inherent bias due to sequence-dependent efficiencies of individual steps.
UC Berkeley researchers discovered variant Csy4 endoribonucleases, nucleic acids encoding the variant Csy4 endoribonucleases, and host cells genetically modified with the nucleic acids that can be used to detect the presence of a particular sequence in a polyribonucleotide, (e.g., to detect the presence of pathogen in a biological sample). . The variant Csy4 endoribonucleases find use in a variety of applications, which are also provided. The present disclosure also provides methods of detecting a specific sequence in a target polyribonucleotide; and methods of regulating production of a target RNA in a eukaryotic cell.